Understanding and using patient experiences as evidence in healthcare priority setting

Autor: Leah Rand, Michael Dunn, Ingrid Slade, Sheela Upadhyaya, Mark Sheehan

Publikováno v: Cost Effectiveness and Resource Allocation, Vol 17, Iss 1, Pp 1-13 (2019)

Abstract Background In many countries, committees make priority-setting decisions in order to control healthcare costs. These decisions take into account relevant criteria, including clinical effectiveness, cost-effectiveness, and need, and are suppo

Externí odkaz: https://doaj.org/article/928af7da64ac4511bfc4c70755f209a1

Controversy Over Using Quality-Adjusted Life-Years In Cost-Effectiveness Analyses: A Systematic Literature Review

Autor: Aaron S. Kesselheim, Leah Rand

Publikováno v: Health Affairs. 40:1402-1410

Researchers and policy makers in the US are exploring the implementation of health technology assessment and value-based pricing to negotiate drug prices and limit spending. Objections made to the quality-adjusted life-year (QALY), the most frequentl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::00ed67de89ce65e689a72058fae7fd1e
https://doi.org/10.1377/hlthaff.2021.00343

International reference pricing for prescription drugs: a landscape analysis

Autor: Aaron S. Kesselheim, Leah Rand

Publikováno v: Journal of managed carespecialty pharmacy. 27(9)

During the Trump administration, members of Congress and the administration proposed the introduction of international reference pricing (IRP) to Medicare in order to reduce US drug spending by benchmarking prices to those in other countries. Many ot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8ad4c7f6bc4219dca0184627e0cef41
https://pubmed.ncbi.nlm.nih.gov/34464208

An International Review of Health Technology Assessment Approaches to Prescription Drugs and Their Ethical Principles

Autor: Aaron S. Kesselheim, Leah Rand

Publikováno v: The Journal of law, medicineethics : a journal of the American Society of Law, MedicineEthics. 48(3)

In many countries, health technology assessment (HTA) organizations determine the economic value of new drugs and make recommendations regarding appropriate pricing and coverage in national health systems. In the US, recent policy proposals aimed at

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d550fe991c396a69124eda8b0daa859
https://pubmed.ncbi.nlm.nih.gov/33021189

Public involvement in the governance of population-level biomedical research: unresolved questions and future directions

Autor: Teresa Finlay, Max Williamson, Rebecca Dawson, Vicky Chico, Oli Williams, Effy Vayena, Sapfo Lignou, Nigel Hughes, A. Evans, Leah Rand, Aaron J. Goldenberg, Sarah Chan, Lisa Hinton, Karin R. Jongsma, Michael Dunn, Mahsa Shabani, Matthew S. McCoy, Rachel Thompson, Barbara Prainsack, Ciara Staunton, Barbara A. Koenig, Sarah Cunningham-Burley, Jessica Bell, Sonja Erikainen, Kinga Varnai, Mark Sheehan, Nick Fahy, Phoebe Friesen, Nils Hoppe, Haidan Chen, Lucy Frith, Julie L Darbyshire, Michael W. Parker, Michael M. Burgess, Michelle L. McGowan, Annie Sorbie

Publikováno v: JOURNAL OF MEDICAL ETHICS
Erikainen, S, Friesen, P, Rand, L, Jongsma, K, Dunn, M, Sorbie, A, McCoy, M, Bell, J, Burgess, M, Chen, H, Chico, V, Cunningham-Burley, S, Darbyshire, J, Dawson, R, Evans, A, Fahy, N, Finlay, T, Frith, L, Goldenberg, A, Hinton, L, Hoppe, N, Hughes, N, Koenig, B, Lignou, S, McGowan, M, Parker, M, Prainsack, B, Shabani, M, Staunton, C, Thompson, R, Varnai, K, Vayena, E, Williams, O, Williamson, M, Chan, S & Sheehan, M 2021, ' Public involvement in the governance of population-level biomedical research : Unresolved questions and future directions ', Journal of Medical Ethics, vol. 47, no. 7, pp. 522-525 . https://doi.org/10.1136/medethics-2020-106530
Journal of Medical Ethics
Erikainen, S, Friesen, P, Rand, L, Jongsma, K, Dunn, M, Sorbie, A, McCoy, M, Bell, J, Burgess, M, Chen, H, Chico, V, Cunningham-Burley, S, Darbyshire, J, Dawson, R, Evans, A, Fahy, N, Finlay, T, Frith, L, Goldenberg, A, Hinton, L, Hoppe, N, Hughes, N, Koenig, B, Lignou, S, McGowan, M, Parker, M, Prainsack, B, Shabani, M, Staunton, C, Thompson, R, Varnai, K, Vayena, E, Williams, O, Williamson, M, Chan, S & Sheehan, M 2020, ' Public involvement in the governance of population-level biomedical research : Unresolved questions and future directions ', Journal of Medical Ethics . https://doi.org/10.1136/medethics-2020-106530

Population-level biomedical research offers new opportunities to improve population health, but also raises new challenges to traditional systems of research governance and ethical oversight. Partly in response to these challenges, various models of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d25f005a3374b6247b0f5fa0905d1013
https://pubmed.ncbi.nlm.nih.gov/33023977